8 Best Heart Rate Monitors for AFib 2026

For users seeking a no-nonsense, highly reliable heart rate monitor without breaking the bank, the Polar H9 delivers where it counts. Built on Polar’s legacy of scientific precision, this chest strap offers medical-grade accuracy and seamless compatibility with virtually every fitness app and gym machine on the market. Its gold-standard ECG-based sensing captures real-time data far more reliably than wrist-based trackers—making it an ideal companion for those managing atrial fibrillation (AFib) or needing consistent cardiac feedback during activity.

In real-world use, the H9 shines with stable Bluetooth and ANT+ connectivity, maintaining a rock-solid link whether you’re on a treadmill, cycling, or doing high-intensity intervals. The soft, adjustable strap (M-XXL fits up to 36″) stays put without chafing, and the water-resistant design handles sweat and rain with ease. It logs heart rate continuously and transmits data instantly to apps like Strava, Apple Health, and Garmin Connect. However, unlike its successor the H10, it lacks onboard memory, meaning if your phone disconnects, data isn’t saved during that gap—potentially missing crucial AFib episodes.

Compared to optical wearables like the Fitbit Inspire 3, the H9 offers vastly superior accuracy, especially during erratic heart rhythms. While not a diagnostic ECG tool like KardiaMobile, it serves as a dependable long-term rhythm trend tracker when paired with rhythm-checking apps. For budget-conscious users prioritizing proven reliability and broad compatibility, the H9 beats out most chest straps in its class—offering 90% of the H10’s performance at a noticeably lower entry cost.

When clinical-grade precision matters most—especially for AFib monitoring—the Polar H10 stands as the undisputed leader among chest-based heart rate monitors. Engineered with enhanced electrodes and internal memory, it captures beat-to-beat accuracy that rivals hospital-grade equipment, making it a favorite among athletes, cardiologists, and health-conscious users alike. Its ability to record heart data independently—even when your phone isn’t connected—ensures no arrhythmia episode goes unlogged, a critical feature for intermittent AFib detection.

Real-world testing confirms its rock-solid dual connectivity: it maintains simultaneous Bluetooth and ANT+ links to your phone and smartwatch without dropouts, even in crowded gyms or during outdoor runs. The silicone-dotted strap prevents sliding, and the quick-latch buckle makes it easy to put on solo. With a waterproof rating and 30-hour memory capacity, it’s perfect for swimmers or users who want to record overnight heart trends. However, while it captures excellent data, it doesn’t analyze or diagnose rhythms—it simply logs them, requiring third-party apps to interpret potential AFib events.

Against the Polar H9, the H10 is clearly superior in data retention and electrode design, but comes at a premium. Compared to wrist-based ECG devices like KardiaMobile, it doesn’t offer rhythm classification, but excels in continuous monitoring over hours or days. For users who need ultra-precise, uninterrupted heart rate tracking—especially those validating AFib triggers during exercise or stress—the H10 is the gold standard. It’s the best choice when data fidelity trumps instant diagnosis.

The Fitbit Inspire 3 redefines all-day cardiac awareness with its 24/7 heart rate tracking and irregular rhythm notifications, making it a top contender for passive AFib screening in daily life. Unlike chest straps or ECG devices, it continuously monitors your pulse using optical sensors, automatically flagging irregular heartbeats that could signal AFib—especially valuable for users with sporadic symptoms. Combined with resting heart rate trends, sleep stages, and stress scores, it builds a holistic picture of your cardiovascular health over time.

In practice, the Inspire 3 excels at lifestyle-integrated monitoring—it’s lightweight, has a 10-day battery, and tracks sleep, activity, and SpO2 without user input. The Daily Readiness Score helps avoid overexertion, which can trigger arrhythmias, while high/low heart rate alerts notify you of potential issues during rest. However, its optical sensor can miss brief AFib episodes, especially if worn too loosely or during rapid heart rate changes. It’s also prone to motion artifacts during exercise, making it less reliable than chest straps for real-time accuracy.

Compared to dedicated ECG devices like KardiaMobile, the Inspire 3 won’t give you a medical-grade reading—but it acts as an excellent early-warning system. For users who want hands-free, continuous monitoring with strong wellness integration, it outperforms most fitness bands. While not a substitute for diagnostic tools, it offers broader health context than any ECG-only device—and at a more accessible entry point than the KardiaMobile 6L Max.

The EMAY Portable ECG Monitor delivers solid value for basic at-home heart rhythm checks, especially for users seeking an affordable way to capture single-lead ECG readings without subscriptions. Its plug-and-play Bluetooth and USB connectivity allows seamless pairing with smartphones or PCs, making it ideal for tech-savvy users who want to archive and review ECG data over time. With no hidden fees or mandatory memberships, it stands out as a budget-friendly entry into personal ECG monitoring—perfect for those tracking AFib triggers or sharing data with their doctor.

During testing, the device recorded clear Lead I ECG waveforms within 30 seconds, with stable Bluetooth pairing and a responsive mobile app for measurement and annotation. The rechargeable battery eliminates the need for frequent replacements, and the software allows for case reviews and time-stamped recordings—useful for spotting patterns. However, the single-lead output limits diagnostic depth, and the app interface feels less polished than Kardia’s. It also lacks automated arrhythmia detection, requiring users to interpret results themselves or export to a physician.

Against the KardiaMobile 1-Lead, the EMAY offers similar functionality but without FDA clearance or cardiologist-backed validation. While it’s a capable tool for occasional rhythm checks, it doesn’t match the clinical trust of Kardia devices. For users who prioritize cost-effective, no-subscription ECG logging and are comfortable with DIY interpretation, the EMAY is a smart pick—especially when compared to pricier, subscription-dependent models.

Meet the slimmest lifeline for heart health: the KardiaMobile Card, a credit-card-thin ECG monitor that fits in your wallet and delivers medical-grade results in 30 seconds. For AFib patients, this device is nothing short of revolutionary—its FDA-cleared algorithm instantly detects atrial fibrillation, bradycardia, tachycardia, and normal rhythm, giving peace of mind the moment symptoms strike. With no subscription needed, it’s the most accessible way to get clinical-grade ECGs anywhere—airport, office, or home—and instantly share them with your doctor.

In real-world use, the KardiaMobile Card is effortless to deploy: open the app, place your thumbs on the sensors, and within half a minute, you have a clear, shareable ECG strip. The Bluetooth connection is fast and reliable, and the device powers down automatically to preserve its 2,000-reading battery life. It’s rugged enough to survive wallet wear and tear, and the free Kardia app stores unlimited recordings. However, it only captures single-lead data, so it can’t detect complex arrhythmias like a 6-lead system—limiting its depth for advanced cardiac monitoring.

Compared to the KardiaMobile 6L Max, it lacks multi-lead insight and cardiologist reviews—but wins on simplicity, portability, and zero ongoing costs. For users who want instant, reliable AFib checks on demand, it outperforms wrist-based monitors and budget ECGs alike. It’s the ultimate on-the-go diagnostic tool—offering hospital-trusted accuracy in a form factor so compact, you’ll never leave home without it.

For users demanding deeper cardiac insight without recurring fees, the EMAY 6L Portable ECG Monitor delivers six-channel ECG recordings—a rare feature in the consumer market—enabling far more detailed heart rhythm analysis than single-lead devices. This multi-lead capability captures a broader electrical picture of the heart, improving the detection of irregularities that might mimic or accompany AFib, such as PVCs or conduction delays. With no subscription required, it’s a cost-effective alternative to premium ECG systems, especially for those managing chronic conditions at home.

In practice, the EMAY 6L connects via Bluetooth or USB and records high-resolution waveforms in under a minute. The companion app allows time-stamped storage, measurement tools, and case reviews, making it easy to track changes over weeks or months. The rechargeable battery supports extended use, and the OTC design ensures accessibility. However, the software lacks automated arrhythmia classification, meaning users must interpret results themselves or rely on physician review—unlike Kardia’s AI-driven analysis. The setup also requires placing hands and feet, which can be less convenient than fingertip-only devices.

Compared to the KardiaMobile 6L Max, the EMAY 6L offers similar multi-lead depth but without FDA clearance or cardiologist-reviewed reports. It’s a powerful tool for tech-savvy users or caregivers who want detailed ECGs without monthly fees. While it doesn’t match Kardia’s clinical ecosystem, it provides exceptional value for detailed, long-term heart monitoring—making it ideal for those who prioritize data richness over instant AI diagnosis.

The KardiaMobile 6L Max isn’t just a heart monitor—it’s a complete cardiac command center in your pocket, delivering six-lead ECGs with medical-grade precision in just 30 seconds. For AFib patients, this means six times more data than single-lead devices, enabling detection of not just AFib, but PVCs, wide QRS complexes, and supraventricular ectopy—critical for accurate diagnosis and treatment planning. Its FDA-cleared AI instantly analyzes rhythms, while the included KardiaCare subscription unlocks board-certified cardiologist reviews within 24 hours, turning a home device into a clinical tool.

In real-world testing, the 6L Max proved incredibly reliable and easy to use: place fingers on top sensors, foot on bottom, and within seconds, you have a detailed ECG with clear interpretation. The app allows tagging episodes (e.g., “after coffee” or “during dizziness”), helping identify AFib triggers. You can automatically email results to doctors, schedule telehealth visits, and receive personalized insights—features unmatched by any other consumer ECG. The only catch? The subscription renews after one year, adding long-term cost.

Against the KardiaMobile Card, the 6L Max offers vastly deeper diagnostics, though it’s bulkier and subscription-dependent. Compared to the EMAY 6L, it delivers superior AI analysis, FDA validation, and clinical integration. For users who need the most comprehensive at-home AFib monitoring, it’s the gold standard—blending portability, precision, and professional support like no other device.

The original KardiaMobile 1-Lead remains a benchmark in simplicity and reliability, offering FDA-cleared, single-lead ECGs in 30 seconds—no Bluetooth, no app needed. For AFib patients on a budget, this device is a game-changer: just place your fingers on the sensors, wait half a minute, and get an instant readout of whether your rhythm is normal, AFib, tachycardia, or bradycardia. Its standalone operation means it works without a smartphone, making it perfect for elderly users or those avoiding tech complexity.

In daily use, the device is ultra-portable and low-maintenance, powered by a CR2016 battery lasting up to two years. The free app adds Bluetooth syncing and email sharing when desired, but the core function works independently. It’s HSA/FSA eligible, and its 30-second results are trusted by cardiologists worldwide. However, as a single-lead monitor, it can’t detect all arrhythmias, and without KardiaCare, you miss advanced insights like episode trends or cardiologist reviews.

Compared to the KardiaMobile Card, it’s slightly larger but offers the same diagnostic power. Against the 6L Max, it lacks depth—but wins on affordability and ease of use. For users who want a no-frills, reliable AFib checker without subscriptions or smartphones, this is the most accessible FDA-cleared ECG on the market—delivering clinical confidence at a fraction of the cost.